Excited to welcome Philip Astley-Sparke to SynOx Therapeutics. This transition is a signal of where we’re going as a company. With our Phase 3 program well underway, a strengthened U.S. presence, and growing momentum, we’re entering a time of real possibility. #TGCT#PVNS
@JenWilliams_FT Thank you for sharing this Jennifer. I can see elements of my own secondary education in Greater Manchester 40-years ago. The real tragedy is that we appear to be going backwards and willing to accept a complete polarisation of opportunity and quality of life in the U.K.
@sweatystartup In September 2007 I came to a similar conclusion about Northern Rock and thought the markets had overreacted. I was spectacularly wrong. The depositors had the statutory FSC guarantee of £85k but shareholders were toast.
@campbellclaret I also really do hope that he has to suffer the indignity of queuing in the non-EU passport control line. No doubt he will be whisked through the VIP lanes and tell us all there is no problem.
@campbellclaret Maybe he’s going to visit the European Medicines Agency, which had to relocate from London to Amsterdam taking with it ~1000 highly skilled jobs in a key growth industry .
Today is Rare Disease Day and it’s a day to raise awareness for the 300 Million people in the world with over 6000 rare diseases.
If you or a loved one have a rare disease write it in the comments and make it seen.
#RareDisease#RareDiseaseDay#RareDiseaseDay2023
📢Calling all drug developers - please can you complete the survey below on the role of AI / machine learning to inform a @wellcometrust landscaping report 👇